FIELD: medicine, pharmacology, pharmacy.
SUBSTANCE: invention relates to composition possessing an anti-inflammatory effect and useful for oral administration in form of emulsion preliminary concentrate. Composition comprises NO-releasing nonsteroid anti-inflammatory drug, surface-active substance, oil or semisolid fat and forms in situ emulsion of type oil-in-water after contact with aqueous medium, such as gastroenteric fluid. Also, invention relates to a medicinal formulation based on thereof, oral emulsion, set based on thereof and a method for treatment of inflammation and pain. Proposed compositions possess the improved availability.
EFFECT: improved and valuable properties of composition.
40 cl, 1 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW SELF-EMULSIFIED DRUG DELIVERY SYSTEM | 2001 |
|
RU2275908C2 |
| PHARMACEUTICAL COMPOSITION OF NITROXY DERIVATIVE NONSTEROID ANTI-INFLAMMATORY DRUGS | 2006 |
|
RU2406482C2 |
| SOLID PHARMACEUTICAL COMPOSITION CONTAINING BENZOFURAN DERIVATIVES | 1998 |
|
RU2191578C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES OF N-SULFONYLINDOLINE | 1997 |
|
RU2174394C2 |
| ORALLY ADMINISTRATED LIQUID COMPOSITIONS COMPRISING GUAIFENESIN AND POLYOXYALKYLENE BLOCK-COPOLYMERS | 2002 |
|
RU2281087C2 |
| SOLID DOSED OUT FORMS INCLUDING FIBRAT AND STATIN | 2004 |
|
RU2343905C2 |
| COMPOSITIONS AND METHODS FOR GASTRIC ACID SECRETION INHIBITION WITH USING SMALL DICARBOXYLIC ACID DERIVATIVES IN COMBINATION WITH PPI | 2007 |
|
RU2467747C2 |
| SOLID COMPOSITIONS CONTAINING 5-AMINOLEVULINIC ACID | 2010 |
|
RU2527328C2 |
| SEMIFIRM SYSTEMS CONTAINING DERIVATIVES OF AZETIDINUM | 2004 |
|
RU2343915C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HELICOBACTER PYLORI | 2014 |
|
RU2671400C2 |
